Gene Editing Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant Posted on April 29, 2022 by Editorial Staff Researchers examined the characteristics and outcomes of COVID-19 in immunocompromised patients. Share on FacebookTweetFollow us Editorial Staff Chimeric Delta-Omicron RBD-dimer vaccine found to be effective against SARS-CoV-2 variants STAT+: Pharmalittle: Investors reject proposals for Covid vaccine makers to share know-how; CMS head says Alzheimer’s drug decision is rare